Relevance of randomised controlled trials in oncology
Ian F. Tannock(Princess Margaret Cancer Centre), Francisco Vera-Badillo(Queen's University), Arnoud J. Templeton(University of Basel), Alberto Ocaña(Universidad San Pablo CEU), Christopher M. Booth(Queen's University), Saroj Niraula(University of Manitoba), Eitan Amir(Princess Margaret Cancer Centre), Boštjan Šeruga(University of Ljubljana)
Cited by 116
Related Papers
Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial
|The Lancet|2014|1.8k
Clinical Features and Short-term Outcomes of 144 Patients With SARS in the Greater Toronto Area
|JAMA|2003|1.4k
Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer
|JAMA|2011|632
Randomised controlled trials and population-based observational research: partners in the evolution of medical evidence
|British Journal of Cancer|2014|470